4.8 Article

The C9orf72 repeat expansion disrupts nucleocytoplasmic transport

期刊

NATURE
卷 525, 期 7567, 页码 56-+

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/nature14973

关键词

-

资金

  1. NIH [R01NS085207, NS091046, R01 NS082563, R01 NS074324, NS089616, CA009110]
  2. Brain Science Institute
  3. Robert Packard Center for ALS Research at Johns Hopkins
  4. Muscular Dystrophy Association
  5. Alzheimer's Drug Discovery Foundation
  6. Judith and Jean Pape Adams Charitable Foundation
  7. Alzheimer's Disease Research Center - Johns Hopkins
  8. Maryland TEDCO
  9. Target ALS Springboard Fellowship
  10. William and Ella Owens Foundation
  11. ALS Association
  12. NIH K99 award [NS091486]
  13. National Science Foundation Graduate Research Fellowship
  14. Thomas Shortman Training Fund Graduate Scholarship

向作者/读者索取更多资源

The hexanucleotide repeat expansion (HRE) GGGGCC (G(4)C(2)) in C9orf72 is the most common cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Recent studies support an HRE RNA gain-of-function mechanism of neurotoxicity, and we previously identified protein interactors for the G(4)C(2) RNA including RanGAP1. A candidate-based genetic screen in Drosophila expressing 30G(4)C(2) repeats identified RanGAP (Drosophila orthologue of human RanGAP1), a key regulator of nucleocytoplasmic transport, as a potent suppressor of neurodegeneration. Enhancing nuclear import or suppressing nuclear export of proteins also suppresses neurodegeneration. RanGAP physically interacts with HRE RNA and is mislocalized in HRE-expressing flies, neurons from C9orf72 ALS patient-derived induced pluripotent stem cells (iPSC-derived neurons), and in C9orf72 ALS patient brain tissue. Nuclear import is impaired as a result of HRE expression in the fly model and in C9orf72 iPSC-derived neurons, and these deficits are rescued by small molecules and antisense oligonucleotides targeting the HRE G-quadruplexes. Nucleocytoplasmic transport defects may be a fundamental pathway for ALS and FTD that is amenable to pharmacotherapeutic intervention.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据